$0.67 in average volume shows that Bionano Genomics Inc (BNGO) is heading in the right direction

Bionano Genomics Inc (NASDAQ: BNGO) kicked off on Friday, up 1.23% from the previous trading day, before settling in for the closing price of $9.00. Over the past 52 weeks, BNGO has traded in a range of $1.04-$17.10.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Healthcare Sector giant saw their annual sales surged by 33.61% over the last five years. While this was happening, its average annual earnings per share was recorded -43.74%. With a float of $38.16 million, this company’s outstanding shares have now reached $38.84 million.

Bionano Genomics Inc (BNGO) Insider Activity

Our next focus will be how large-scale investors are participating in this stock of the Medical Instruments & Supplies Industry. The insider ownership of Bionano Genomics Inc is 1.76%, while institutional ownership is 11.64%. The most recent insider transaction that took place on Jun 13, was worth 50,000. In this transaction Director of this company bought 65,789 shares at a rate of $0.76, taking the stock ownership to the 65,789 shares. Before that another transaction happened on May 16, when Company’s President and CEO bought 15,000 for $0.64, making the entire transaction worth $9,639. This insider now owns 806,474 shares in total.

Bionano Genomics Inc (BNGO) Earnings and Forecasts

In the latest quarterly report, which was put into the public domain on 9/29/2023, the organization reported -$3.22 earnings per share (EPS), lower than consensus estimate (set at -$0.97) by -$2.25. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.76 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around -43.74% per share during the next fiscal year.

Bionano Genomics Inc (NASDAQ: BNGO) Trading Performance Indicators

Take a look at Bionano Genomics Inc’s (BNGO) current performance indicators. Last quarter, stock had a quick ratio of 1.94. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.42.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.98, a number that is poised to hit -0.87 in the next quarter and is forecasted to reach -2.50 in one year’s time.

Technical Analysis of Bionano Genomics Inc (BNGO)

Analysing the last 5-days average volume posted by the [Bionano Genomics Inc, BNGO], we can find that recorded value of 1.49 million was lower than the volume posted last year of 1.82 million. As of the previous 9 days, the stock’s Stochastic %D was 50.26%. Additionally, its Average True Range was 0.11.

During the past 100 days, Bionano Genomics Inc’s (BNGO) raw stochastic average was set at 9.10%, which indicates a significant decrease from 52.78% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 59.96% in the past 14 days, which was lower than the 90.54% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $1.4914, while its 200-day Moving Average is $3.7001. Now, the first resistance to watch is $1.2567. This is followed by the second major resistance level at $1.2833. The third major resistance level sits at $1.3267. If the price goes on to break the first support level at $1.1867, it is likely to go to the next support level at $1.1433. Should the price break the second support level, the third support level stands at $1.1167.

Bionano Genomics Inc (NASDAQ: BNGO) Key Stats

The company with the Market Capitalisation of 47.77 million has total of 38,840K Shares Outstanding. Its annual sales at the moment are 27,800 K in contrast with the sum of -132,600 K annual income. Company’s last quarter sales were recorded 9,320 K and last quarter income was -112,570 K.